{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Upshot", "lead_paragraph": "Experts question the effectiveness of H.P. Acthar Gel, a drug made from pigs\u2019 pituitary glands. Yet it cost Medicare more than $141 million in 2012, up from $7 million in 2008.", "headline": {"main": "The Obscure Drug With a Growing Medicare Tab", "kicker": "The Upshot", "print_headline": "An Obscure Drug Rings Up a Growing Medicare Tab", "content_kicker": "Losing Cost Control "}, "abstract": "The Upshot; experts question effectiveness of HP Acthar Gel, drug made from pigs\u2019 pituitary glands, which cost Medicare more than $141 million in 2012, up from $7 million in 2008; explosive growth illustrates how Medicare's prescription drug program is struggling to contain taxpayer burden of expensive therapies aimed at rare conditions.", "print_page": "3", "word_count": "2100", "_id": "53df9ff8798810168b3f698b", "snippet": "Experts question the effectiveness of H.P. Acthar Gel, a drug made from pigs\u2019 pituitary glands. Yet it cost Medicare more than $141 million in 2012, up from $7 million in 2008.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/05/upshot/the-obscure-drug-with-a-growing-medicare-tab.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/05/upshot/05up-submedchart-1406931137776/05up-submedchart-1406931137776-thumbWide.png", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/05/upshot/05up-submedchart-1406931137776/05up-submedchart-1406931137776-thumbWide.png", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/05/upshot/05up-submedchart-1406931137776/05up-submedchart-1406931137776-articleLarge.png", "height": 450, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/05/upshot/05up-submedchart-1406931137776/05up-submedchart-1406931137776-articleLarge.png", "xlargeheight": "450"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/05/upshot/05up-medicare/05up-medicare-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/05/upshot/05up-medicare/05up-medicare-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Questcor Pharmaceuticals Incorporated", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Seizures (Medical)", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Mallinckrodt Pharmaceuticals", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Acthar (Drug)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Medicare", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Charles", "lastname": "ORNSTEIN"}], "original": "By CHARLES ORNSTEIN"}, "document_type": "article", "pub_date": "2014-08-05T00:00:00Z", "section_name": "The Upshot"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Two American aid workers infected with Ebola are getting an experimental drug so novel it has never been tested for safety in humans and was only identified as a potential treatment earlier this year, thanks to a longstanding research program by the U.S. government and the military.", "headline": {"main": "US Gov't Had Role in Ebola Drug Given Aid Workers", "print_headline": "US Gov't Had Role in Ebola Drug Given Aid Workers"}, "abstract": null, "print_page": null, "word_count": "1128", "_id": "53df3fac798810168b3f68b0", "snippet": "Two American aid workers infected with Ebola are getting an experimental drug so novel it has never been tested for safety in humans and was only identified as a potential treatment earlier this year, thanks to a longstanding research program by the...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/08/04/us/ap-us-ebola-americans.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-08-04T04:08:30Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "EdLife", "lead_paragraph": "With a looming shortage of M.D.s, osteopathic medicine is shedding its second-tier image. And yes, D.O.s are real doctors.", "headline": {"seo": "Osteopathic Schools Turn Out Nearly a Quarter of All Med School Grads", "main": "The D.O. Is in Now", "print_headline": "The D.O. Is In Now"}, "abstract": "Osteopathic medicine, field in which doctors manipulate spine, muscles and bones in diagnosis and treatment, was once considered secondary to conventional medicine but is beginning to attract both more respect and more students; many are drawn to field for its more personal, hands-on approach and emphasis on community medicine and preventative care.", "print_page": null, "word_count": "2137", "_id": "53d79a227988104972f050ff", "snippet": "With a looming shortage of M.D.s, osteopathic medicine is shedding its second-tier image. And yes, D.O.s are real doctors.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/03/education/edlife/the-osteopathic-branch-of-medicine-is-booming.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/03/education/edlife/03OSTEO2/OSTEO2-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/03/education/edlife/03OSTEO2/OSTEO2-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/03/education/edlife/03OSTEO2/OSTEO2-articleLarge.jpg", "height": 397, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/03/education/edlife/03OSTEO2/OSTEO2-articleLarge.jpg", "xlargeheight": "397"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/03/education/edlife/03OSTEO2/OSTEO2-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/03/education/edlife/03OSTEO2/OSTEO2-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Education Life", "keywords": [{"value": "Medical Schools", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Doctors", "is_major": "Y", "rank": "2", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Joseph", "lastname": "BERGER"}], "original": "By JOSEPH BERGER"}, "document_type": "article", "pub_date": "2014-08-03T00:00:00Z", "section_name": "Education"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Entrepreneurs hope to develop innovative drugs for dogs and cats like those that have revolutionized the treatment of diseases like cancer in people.", "headline": {"main": "Start-Ups Work on Biotech Drugs for Pets", "print_headline": "Cures for Canines"}, "abstract": "Start-ups in biotechnology are turning their attention to developing innovative drugs for dogs and cats like those that have revolutionized treatment of diseases like cancer and arthritis in humans; companies say that with people increasingly viewing pets as family members, both motive and profit support such efforts.", "print_page": "1", "word_count": "1282", "_id": "53dbed6e7988100ecfce93a4", "snippet": "Entrepreneurs hope to develop innovative drugs for dogs and cats like those that have revolutionized the treatment of diseases like cancer in people.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/02/business/biotechnology-for-treating-dogs-and-cats.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/02/business/02pets-pic3/02pets-pic3-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/02/business/02pets-pic3/02pets-pic3-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/02/business/PETS1/PETS1-articleLarge.jpg", "height": 384, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/02/business/PETS1/PETS1-articleLarge.jpg", "xlargeheight": "384"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/02/business/PETS1/PETS1-thumbStandard-v2.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/02/business/PETS1/PETS1-thumbStandard-v2.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Cats", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Nexvet Biopharma Pty Ltd", "is_major": "N", "rank": "8", "name": "organizations"}, {"value": "Start-ups", "is_major": "N", "rank": "10", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Pets", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Dogs", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "CanFel Therapeutics", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Biotechnology", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Veterinary Medicine", "is_major": "Y", "rank": "6", "name": "subject"}, {"value": "VetDC", "is_major": "N", "rank": "9", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2014-08-02T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "United States health officials say they aim to test a vaccine shown to protect macaque monkeys as early as next month.", "headline": {"main": "Ebola Vaccine Possible, but Many Doubts Persist", "print_headline": "Ebola Vaccine Possible, but Many Doubts Persist"}, "abstract": "United States health officials say they are planning fast-track development of an Ebola vaccine, aiming to test it as early as September; scientists warn task is arduous and success is hardly guaranteed, particularly in light of fact that financial investment from pharmaceutical industry is perhaps most crucial contingency.", "print_page": "10", "word_count": "884", "_id": "53dbbf7b7988100ecfce92e8", "snippet": "United States health officials say they aim to test a vaccine shown to protect macaque monkeys as early as next month.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/02/health/effort-to-develop-ebola-vaccine-to-test-on-humans-is-put-on-fast-track.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Vaccination and Immunization", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Ebola Virus", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Fauci, Anthony S", "is_major": "N", "rank": "4", "name": "persons"}], "byline": {"contributor": "", "person": [{"firstname": "Roni", "middlename": "Caryn", "lastname": "RABIN", "rank": 1, "role": "reported", "organization": ""}], "original": "By RONI CARYN RABIN"}, "document_type": "article", "pub_date": "2014-08-02T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "In the four decades since the Ebola virus was first identified in Africa, treatment hasn't changed much. There are no licensed drugs or vaccines for the deadly disease.", "headline": {"main": "Why Isn't There a Treatment or Vaccine for Ebola?", "print_headline": "Why Isn't There a Treatment or Vaccine for Ebola?"}, "abstract": null, "print_page": null, "word_count": "671", "_id": "53dbe5f47988100ecfce9384", "snippet": "In the four decades since the Ebola virus was first identified in Africa, treatment hasn't changed much. There are no licensed drugs or vaccines for the deadly disease.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2014/08/01/health/ap-eu-med-ebola-treatment.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2014-08-01T15:08:08Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": null, "lead_paragraph": "Jenneh became a nurse in Sierra Leone 15 years ago with the hope of saving lives in one of the world's poorest countries. Now she fears for her own after three of her colleagues died of Ebola.", "headline": {"main": "Exposure of Health Workers Weakens Africa's Ebola Fight", "print_headline": "Exposure of Health Workers Weakens Africa's Ebola Fight"}, "abstract": null, "print_page": null, "word_count": "1576", "_id": "53dba7f679881078147de086", "snippet": "Jenneh became a nurse in Sierra Leone 15 years ago with the hope of saving lives in one of the world's poorest countries. Now she fears for her own after three of her colleagues died of Ebola.", "source": "Reuters", "slideshow_credits": null, "web_url": "http://www.nytimes.com/reuters/2014/08/01/world/africa/01reuters-health-ebola-healthworkers.html", "multimedia": [], "subsection_name": "Africa", "keywords": [], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2014-08-01T10:43:26Z", "section_name": "World"}, {"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Ask Well: Do I Need a Measles Shot?", "kicker": "Well", "print_headline": "Ask Well"}, "abstract": "I haven\u2019t been vaccinated against measles since I was a child in the 1950s. Should older adults get another vaccination?", "print_page": null, "word_count": "531", "_id": "53db8fbc79881078147de022", "snippet": "I haven\u2019t been vaccinated against measles since I was a child in the 1950s. Should older adults get another vaccination?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2014/08/01/ask-well-do-i-need-a-measles-shot/", "multimedia": [{"subtype": "wide", "url": "images/2014/07/30/science/mmr-vaccine/mmr-vaccine-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/07/30/science/mmr-vaccine/mmr-vaccine-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/07/30/science/mmr-vaccine/mmr-vaccine-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/07/30/science/mmr-vaccine/mmr-vaccine-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/07/30/science/mmr-vaccine/mmr-vaccine-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/07/30/science/mmr-vaccine/mmr-vaccine-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Vaccination and Immunization", "name": "subject", "rank": "3"}, {"value": "Medicine and Health", "name": "subject", "rank": "2"}, {"value": "Measles", "name": "subject", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "blogpost", "pub_date": "2014-08-01T09:00:28Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The Food and Drug Administration said it felt the need to act to ensure the safety of home-brew test systems that are being developed and marketed widely.", "headline": {"main": "F.D.A. Acts on Lab Tests Developed In-House", "print_headline": "F.D.A. Acts on Lab Tests Developed in-House"}, "abstract": "Food and Drug Administration will start regulating medical laboratory testing, move fiercely opposed by some laboratories and pathologists, who say it will increase cost and time needed to develop tests, stifling innovation and depriving patients of some critical tools; FDA will phase in the requirements over nine years and will focus on tests that involve highest level of risk to patients.", "print_page": "1", "word_count": "1149", "_id": "53da79c779881078147ddcdc", "snippet": "The Food and Drug Administration said it felt the need to act to ensure the safety of home-brew test systems that are being developed and marketed widely.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/01/business/fda-to-regulate-lab-developed-test-kits.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/01/business/Labtest1/Labtest1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/01/business/Labtest1/Labtest1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/01/business/Labtest1/Labtest1-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/01/business/Labtest1/Labtest1-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/01/business/01labtest-pic1/01labtest-pic1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/01/business/01labtest-pic1/01labtest-pic1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Hamburg, Margaret A", "is_major": "N", "rank": "5", "name": "persons"}, {"value": "Tests (Medical)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Laboratories and Scientific Equipment", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "Y", "rank": "2", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2014-08-01T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 19, "offset": 10, "time": 270}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}